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Expression of osteopontin, a urinary inhibitor of stone mineral crystal
growth, in rat kidney. Cultured mouse kidney cortical cells secrete
osteopontin, a bone matrix protein that is also found in urine. Osteopontin
is associated with cell proliferation/tumerogenesis and also inhibits kidney
stone mineral crystal growth [1}. Using antibodies raised against osteopon-
tin isolated from the culture medium, we localized osteopontin in normal
rat kidney. Fluorescence, confocal and electron microscopy revealed
osteopontin primarily in cells of the descending thin limb of the loop of
Henle (DTL) and in papillary surface epithelium (PSE) in the area of the
calyceal fornix. In situ hybridization with labeled RNA made from a eDNA
that contains the entire coding sequence for mouse osteopontin revealed
message at the same sites at which protein was demonstrated by immu-
nocytochemistry. Immunogold labeling was localized to a population of
dense vesicles distinct from lysosomes and endosomes. To examine the
turnover of osteopontin, rats were injected with the protein synthesis
inhibitor cyclohexamide, 14 mg/kg, six hours prior to kidney fixation.
These kidneys no longer demonstrated osteopontin in DTL and the
immunofluorescence in the papillary surface was attenuated. Thus, os-
teopontin is secreted at two sites in the kidney where urine is highly
concentrated in stone mineral constituents. It has a relatively rapid
turnover, suggesting that it could be subject to physiological regulation.
Osteopontin may be important in the normal endogenous defense against
kidney stone formation.
Urine contains inhibitors of stone mineral crystal growth [21.
These may be responsible, in part, for the relative infrequency of
nephrolithiasis and urolithiasis despite supersaturation of tubular
fluid and urine in the chemical constituents of calcium-containing
urinary calculi. Most of the inhibitory activity of urine is due to
proteins [3, 41.
Two proteinaceous inhibitors of calcium oxalate crystal growth
have so far been identified [2]. Nephrocalcin is an acidic glyco-
protein containing the somewhat unusual residue y-carboxyglu-
tamic acid. This protein has not been completely characterized.
Worcester et al recently reported the isolation of a second stone
mineral crystal growth inhibitory protein from the medium of
primary cultures of mouse kidney cortex cells [1]. Since the first 21
amino acids of this isolate match the N-terminus of the bone
phosphoprotein, osteopontin, and, in addition, antibodies raised
to fusion proteins containing N- or C-terminal portions of os-
teopontin recognize the isolate, this protein has been considered
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to be very closely related, if not identical, to osteopontin. Re-
cently, an inhibitory protein called uropontin, identical to human
osteopontin, has been isolated from human urine [5]. Thus, it
seems likely that osteopontin or related proteins are part of the
normal defense against formation of urinary calculi. Furthermore,
it is possible that abnormalities in the secretion or processing of
osteopontin may play a role in the pathophysiology of nephroli-
thiasis.
In the present study, we have examined the immunocytochem-
ical expression of osteopontin in normal rat kidney using an
antibody raised against the protein isolated from mouse cortical
cell culture medium. Examination by conventional fluorescence,
as well as confocal and electron microscopy of sections cut by a
number of techniques has identified osteopontin primarily in cells
of the descending thin limb of the loop of Henle (DTL) and in
papillary surface epithelium (PSE) in the area of the calyceal
fornix. The immunocytochemical signal has been localized to a
population of presumed secretory vesicles distinct from lysosomes
and endosomes. Thus, this urinary inhibitor of crystal growth may
be secreted at sites proximate to that of the greatest degree of
supersaturation of the components of calcium-containing kidney
stones.
Methods
Isolation of osteopontin from mouse cortical cell culture me-
dium, characterization of its calcium oxalate crystal inhibitory
activity and generation in rabbits of a polyclonal antiserum against
the protein has previously been described [1]. Affinity purification
of the antiserum was accomplished by incubation with nitrocellu-
lose strips to which purified osteopontin run on 10% SDS-
polyacrylamide gels was blotted [6]. Antibody was bound in 50 mM
Tris-HCI (pH 7.2), 150 mM NaCl, 0.5% Tween-20, containing
0.25% gelatin, at a dilution of 1:50, overnight. Strips were washed
with this solution several times and antibody eluted in 100 mi
glycine-HC1, pH 2.5, 150 mrvt NaCl for five minutes, which was
then neutralized with 1 M Tris-HC1, pH 8. IgG content was
determined in a sandwich ELISA, using purified rabbit IgG
(Sigma, St. Louis, MO, USA) as the standard, and unlabeled goat
anti-rabbit IgG as the capture antibody. IgG from nonimmune
serum was eluted from a Protein A column (Pierce, Rockford, IL,
USA) and was adsorbed by incubation with immobilized Os-
teopontin as described above, at a concentration of approximately
0.5 ml serum per mg antigen. IgG concentration was determined
as above. The polyclonal antilysosomal glycoprotein (LGP12O)
1585
1586 Kleinman et al. Osteopontin in rat kidney
antibody was provided by I. Meliman (Yale University Medical
School, New Haven, CT, USA).
All the animals used in this study were virus and pathogen-free,
mature male 200 to 250 g Sprague-Dawley rats. A total of 15
different rats were used for immunocytochemistry; five for the
immunoperoxidase and immunofluorescence cytochemistry on
5 m sections, two each for the FITC-Dextran infusions, the
ultrathin frozen sections, the 1 tm Epon sections and the in situ
hybridization studies. Localization of LGP 120 in the normal and
osteopontin after cyclohexamide treatment were performed in
one animal each.
Rats were anesthetized with sodium pentobarbital. Bladder
urine was collected, and the following protease inhibitors were
added from concentrated stocks to the indicated final concentra-
tions: 1 M leupeptin, 200 iM PMSF, 1 M pepstatin and 100 ILM
EDTA. The urine from several rats was pooled and frozen at
— 80°C until analysis. ELISA was performed as previously de-
scribed [1].
Rat kidneys for peroxidase immunocytochemistiy were re-
moved and fixed in formalin, paraffin-embedded, and 5 tm
sections cut. Sections were dewaxed by incubation in xylene
followed by incubations in progressively decreasing concentra-
tions of ethanol, and finally in water. Endogenous peroxidase was
blocked by incubation with 0.3% H202 in methanol for 20
minutes. Slides were blocked with 2% bovine serum albumin in
PBS, pH 7.2, containing 15 pi/ml nonimmune goat serum for one
hour, then incubated with either anti-osteopontin or non-immune
serum at a dilution of 1:1000 in the same buffer (without goat
serum) for 150 minutes at room temperature. Slides were washed
with PBS several times, then incubated with biotinylated goat
anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA)
1:200 for one hour. Slides were washed with PBS, then incubated
with Extravidin-peroxidase (Sigma Chemicals, St. Louis, MO,
USA) 1:220 for 30 minutes. Color was developed with diamino-
benzidine for two minutes, then rinsed in PBS. Sections were
counterstained with Harris hematoxylin, dehydrated through pro-
gressive alcohol washes, and mounted with Permount.
Kidneys were fixed for immunocytochemistry of frozen or
plastic embedded sections by perfusion with a paraformaldehyde-
periodate-lysine fixative as previously described [7]. Some animals
were injected intravenously 20 minutes prior to fixation with a
solution of 3.125 mg/ml fixable FITC-Dextran (Molecular Probes,
Eugene, OR, USA) in Hank's buffer [7]. Tissue was infiltrated in
30% sucrose overnight and 5 m sections were cut and mounted
on Superfrost/Plus microscope slides (Fisher Scientific, Pitts-
burgh, PA, USA). Tissue was also infiltrated with 2.3 M sucrose
overnight, cut into ultrathin (60 nm) sections and mounted on
carbon/Parlodion-coated, nickel grids. In addition, some of the
tissue was cut into 1 mm cubes and dehydrated through a series of
graded ethanols and embedded in Epon. Indirect immunocyto-
chemistry was performed on thin frozen sections using fluorescein
or rhodamine conjugated secondary antibodies as previously
described [8]. Indirect immunofluorescence on semithin Epon-
embedded tissue was performed in a similar manner after Epon
removal with a solution containing 2 g KOH in 10 ml methanol
and 5 ml propylene oxide [9]. Incubation of ultrathin frozen
sections with primary and secondary antibodies, 8 nm protein
A-gold conjugates and counterstaining was performed as previ-
ously described [8]. Except where specifically indicated, sections
were incubated with the unpurified osteopontin antiserum. Dilu-
tions of either 1:500 or 1:250 were used. The LGP 120 antiserum
was used at a dilution of 1:100. When sections were incubated in
affinity-purified osteopontin antiserum, it was used undiluted.
Thin and semi-thin sections were examined and photographed
using a Nikon FXA microscope equipped for epifluorescence.
Kodak Tmax-400 film was used at a setting of 1600 ASA. Some
sections were also examined using the Biorad MRC600 confocal
microscope. Ultrastructural examination was performed using a
Phillips CM1O electron microscope.
A probe for in situ hybridization was prepared from a cDNA for
osteopontin (2ar) supplied by D. T. Denhardt (Rutgers Univer-
sity, Piscataway, NJ, USA). The plasmid was linearized with Eco
Ri and PST1, and transcription was accomplished in the presence
of [35S]-UTP with T7 and SP6 RNA polymerases respectively to
generate single-stranded sense and anti-sense RNA probes.
Five micrometer cryosections of PLP-fIxed rat kidney were
incubated with the probes as previously described by Kanai et al
[10]. Comparison of the protein encoded by 2ar with rat osteopon-
tin was performed using a software package (Genetics Computer
Group, Madison, WI, USA).
Results
Identifi cation of osteopontin in rat urine by ELISA
Using a competitive ELISA with antiserum raised against the
mouse cortical cell culture 80 kDa protein, the concentration of
osteopontin in pooled rat urine was determined to be 6.4 gIml.
This antibody recognizes a band of appropriate Mr in Western
blots of rat urinary protein (data not shown).
Segmental cytochemical identification of osteopontin
By indirect immunoperoxidase staining, osteopontin was found
in two areas of the kidney: along the renal pelvis and in the inner
stripe of the outer medulla (Fig. 1). Staining was most intense in
the calyceal fornix and tapered off both over the papillary surface
towards the tip and over the lateral surface of the calyx. Immu-
nofluorescence on 5 tm frozen sections also showed osteopontin
in tubule cells of the DTL (Fig. 2a). Counterstaining with Evans'
Blue clearly indicated that the osteopontin immunofluorescence
was localized in segments contiguous with tubules possessing a
luxuriant brush border, that is, S3 portions of proximal tubules.
Double staining with an antibody against Tamm-Horsfall glyco-
protein as well as the osteopontin antiserum never gave colocal-
ization (data not shown). Osteopontin was also detected in an
occasional distal tubule or connecting duct segment (Fig. 2b),
identified by its proximity to the glomerulus, lack of brush border
and the presence of a minority population of cells protruding into
the tubular lumen, presumably intercalated cells. The preimmune
serum gave virtually no immunostaining anywhere in the kidney.
Subcellular localization of osteopontin
Indirect immunofluorescence of semi-thin sections suggested
that osteopontin resides mainly within a population of intracellu-
lar vesicles. Both in the DTL (Fig. 3a) and in the PSE (Fig. 3b),
these large vesicles were mainly localized to the apical region of
cells. This was confirmed by immunocytochemistry of ultrathin
frozen sections. Figure 4 shows immunogold localization of
osteopontin on an ultrathin frozen section of PSE. Gold particles
were concentrated in some electron-dense vesicles.
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Fig. 1. Indirect immunoperoxidase staining for osteopontin in a 5 j.un paraffin section of rat kidney. Note reaction product (arrows) along the pelvis (p),
most intense in the calyceal fornix and tapering off both over the papillary surface towards the tip (t) and over the lateral surface of the calyx, and in
the inner stripe of the outer medulla (asterisks). Magnification X 50.
Fig. 2. Osteopontin in inner medulla and connecting tubule. Indirect immunofluorescence on 5 m cryosections showing osteopontin antiserum bound
to cells of the outer medulla (a) and in cells of the connecting tubule or cortical collecting duct (b). Original magnifications )< 320 and X 640,
respectively.
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Fig. 3. Osteopontin in DTL and in subapical vesicles in PSE. Indirect immunofluorescence staining for osteopontin in a 1 im Epon section of outer stripe
(a) showing the transition (arrowheads) between an S3 segment of the proximal tubule with its luxuriant brush border membrane (arrows) and DTL.
Magnification x 840. Indirect immunofluorescence staining for osteopontin in a 1 m Epon section of PSE (b) showing subapical granular staining for
osteopontin in cells lining the renal pelvis (p). Inner medulla is denoted im. Magnification x 990.
Fig. 4. Indirect immunogold staining of an ultrathin frozen sections of PSE using affinity purified antisenm. Note the association of gold particles with
large, electron-dense bodies in the area of the cell cytoplasm between the nucleus (n) and the plasma membrane (arrows) adjacent to the renal pelvis.
Original magnification X 28,500.
Categorization of vesicles containing osteopontin
To determine whether the osteopontin staining observed in
these cells is due to uptake from tubular fluid or urine of protein
made elsewhere, two protocols were used to distinguish these
osteopontin-containing vesicles from endocytotic vesicles and
lysosomes. Tissue from FITC-Dextran injected animals was incu-
bated with the osteopontin antiserum and stained with rhoda-
mine-conjugated secondary antibody. There was little if any
uptake of FITC-Dextran in descending limb cells and, thus, no
colocalization of osteopontin was observed (data not shown). In
the papillary surface, FITC-Dextran uptake into endosomic vesi-
des was observed in some cells; however, the pattern of osteopon-
tin localization was clearly quite different. Specifically, FITC-
Dextran uptake was observed in areas where there was no or little
immunostaining for osteopontin (Fig. 5 a, b), and, conversely, no
FITC-Dextran uptake was observed in other areas where os-
teopontin was detectable (Fig. 5 c, d).
To distinguish osteopontin-containing vesicles from lysosomes,
tissue sections were incubated with an antiserum against the
lysosomal glycoprotein LGP 120 as well as the osteopontin
antiserum. The pattern observed with indirect immunofluores-
cence was clearly different. LGP 120 staining was abundant in S3
proximal tubule segments, mainly in a vesicular pattern in a
subapical and perinuclear distribution (Fig. 6a). Comparing the
image of the LGP 120 staining with the image showing the tissue
counterstaining (Fig. 6b) reveals little if any vesicular LGP 120
staining in the contiguous descending limb (Fig. 6b). Osteopontin
staining, however, was widespread in DTL cells, particularly
concentrated in large vesicles at or near the apical membrane
(Fig. 3a). PSE had a greater amount of LGP 120 immunostaining
than descending limbs. There were some small positive subapical
vesicles, but most of the LGP 120 in this tissue was observed in
large vesicles around the nucleus (Fig. 6c), especially numerous
toward the basal portion of the cells, as we have previously
reported [7]. Indirect immunofluorescence with osteopontin anti-
serum, however, detected vesicles that were mostly in an apical or
subapical location (Fig. 6d). In connecting segment or collecting
duct, the pattern of LGP 120 distribution was not so clearly
different from that of osteopontin (compare Fig. 6e with 2b).
Together with the results of in situ hybridization (vide infra), these
results suggest that osteopontin made and secreted by thin limb
cells may be taken up from the tubular fluid at more distal sites in
the nephron, accounting for some or all of the immunostaining
occasionally observed there.
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Fig. 5. Osteopontin and endocytic vesicles do not colocalize. (a and c) Areas of papillary surface on 5 m cryosections from kidneys of rats perfused with
fluorescein-dextran showing some cells that have taken up the label into endocytotic vesicles. (b and d) The same area photographed to demonstrate
osteopontin by indirect immunofluorescence using a rhodamine-labeled second antibody. Osteopontin is completely absent in some areas where
fluorescein-dextran has been taken up (arrows) and is present (arrowheads) in other areas where no fluorescein-dextran uptake is observed. Original
magnification >< 640.
Localization of osteopontin mRNA osteopontin was localized by immunocytochemistry. No specific
To determine if the sites of osteopontin localization by immu- message was detected in other tubule segments. In contrast, the
nocytochemistry represent sites of production, osteopontin sense probe showed non-specific hybridization throughout the
mRNA was localized using in situ hybridization. The sense and sections (data not shown).
anti-sense probes were made from 2ar, a cDNA containing the Turnover of osteopontin
coding region for a murine homolog of rat osteopontin, a 44 kD As a first step in determining if osteopontin production isbone phosphoprotein. The 21 N-terminal amino acids of the physiologically regulated, turnover of the protein was assessed.
protein against which the antiserum used in the current study was Immunocytochemical localization of osteopontin was performed
raised were identical in sequence to that predicted for 2ar [1]. The in tissue sections after protein synthesis was inhibited. Kidney
anti-sense probe demonstrated silver grains thin segments contig- sections fixed six hours after injecting animals with cyclohexamide,
uous with thick tubules (Fig. 7a). Despite the inability to identify 14 mg/kg body weight, showed complete loss of staining in the
brush borders in these thick tubule profiles, since silver grains DTL and attenuation of immunofluorescence in the PSE (Fig. 8).
were never observed at the beginning of the inner medulla, the
thin tubules so decorated can only be DTL. In addition, silver Discussion
grains were also observed over the PSE (Fig. 7b). Thus osteopon- Human urine is always supersaturated in kidney stone mineral
tin mRNA appears to be present at the same sites where constituents 2J. In particular, with regard to calcium oxalates and
Fig. 6. Osteopontin and lysosomes do not colocalize. Confocal images of anti-LGP 120 on a 5 tm cryosection at a zone of transition, where the brush
border (curved arrow) ends (arrows), between the proximal tubule S3 segment and DTL. (a) The anti-LGP 120 alone. (b) The tissue counterstain.
Lysosomes are abundant below brush borders in the former segment and are rare or absent (arrowheads) in the latter. Original magnification X 320.
(c and d) Localization of LGP 120 and osteopontin (using affinity purified antibody), respectively, in S m cryosections of areas of papillary surface.
Most of the LGP 120 is perinuclear and basal whereas most of the osteopontin is subapical. Original magnification X 320. (e) Localization of LGP 120
in cortical collecting duct demonstrating cells with an apical vesicular location of this lysosomal marker. Original magnification X 640.
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Fig. 7. Renal localization of osteopontin mRNA. In situ hybridization with osteopontin anti-sense [35S]-mRNA of 5 jLm cryosections of inner stripe (a)
and papilla (b). Silver grains are present over cells of DTL (asterisks) Magnification x 780. Silver grains are present over cells of PSE (arrows).
Magnification x 433.
Fig. 8. Effect of cyclohexamide (14 mg/kg, i.p.) on osteopontin expression. Control kidney (a) shows staining in DTL (arrows) and intense fluorescence
along the papillary surface. Six hours after treatment (b), there was loss of staining in DTL and attenuation of staining in papillary surface. Both 5 j.m
clyosections were incubated with the same dilution of antiserum (1:500). Magnification X 385.
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phosphates, the relative supersaturation ranges from several-fold
to 30 to 50-fold. Urine, however, also is inhibitory for stone
mineral crystal growth, apparently by virtue of its content of
naturally occurring inhibitory factors.
These naturally occurring crystal growth inhibitors include
physicochemical factors such as urinary concentration, pH and
temperature, as well as inorganic and organic molecules [2].
Among the organic crystal growth inhibitors, macromolecules
have attracted considerable recent interest. Nephrocalcin, an
acidic glycoprotein shown to slow calcium oxalate crystal growth,
has been isolated from urine, kidney tissue or both in several
different vertebrate species including the rat [11—13]. Although
immunoreactivity of the nephrocalcin has been demonstrated in
proximal tubules and the thick ascending limbs in both human and
mouse kidney [14], further details of its cellular localization or
processing have not been reported.
The other acidic glycoprotein that inhibits stone mineral crystal
growth is uropontin, a urinary protein apparently identical to the
bone matrix protein osteopontin [51. Osteopontin has been stud-
ied somewhat more extensively than nephrocalcin because it has
been cloned and sequenced [15—18]. Osteopontin is a constituent
of normal bone matrix, but it is also found in the organic matrix of
kidney stones [16, 19]. In addition, it is secreted into culture
medium by several renal cell lines and into the urine by the
normal intact kidney [1, 5, 20, 21]. Osteopontin message (mRNA)
can be extracted from the kidney, indicating that this organ is a
site of osteopontin synthesis [22—24]. However, investigations of
the cellular and subcellular distribution of the protein within the
kidney have yielded some conflicting results.
Nomura et al, using an RNA probe made from 2ar, identified
osteopontin message in embryonic and newborn mouse kidney
[24]. In situ hybridization was noted over tubules in the cortex and
extended into the medulla. Presumably, the former are proximal
tubules and the latter ioops of Henle. Collecting ducts in the
cortex were positive in the embryos, but high power examination
of the newborn cortex was not reported. In the medulla, collecting
ducts were felt to be negative. A positive signal was also observed
in the papillary surface but was felt to be an "edge-effect artifact."
Mark et al reported immunostaining in dewaxed paraffin-embed-
ded sections which had been immersion-fixed in paraformalde-
hyde-periodate-lysine fixative [25]. Electron microscopy was also
performed in similarly fixed frozen sections which had been
stained by the immunoperoxidase method prior to embedding.
They used an antiserum raised in rabbit against the 44 kD bone
matrix protein. Immunofluorescence was primarily observed in
the outer stripe of the outer medulla. Sections stained for both
osteopontin by immunoperoxidase and alkaline phosphatase by
an azo-dye method showed colocalization. The ultrastructure
showed staining product in large subapical vesicles and in "lyso-
some-like bodies" throughout the cell. They interpreted this
localization to reflect endocytotic uptake of filtered protein.
Reinholt et al, in studies reported in abstract form, used a
polyclonal antibody against recombinant rat osteopontin to per-
form immunocytochemical staining in rat tissues [26]. Staining
was observed in renal papillae which was especially intense on
basolateral cell surfaces and less so on luminal cell surfaces,
although of which cell type is unclear. Within cells, osteopontin
was apparently observed in mitochondria. Ullrich et al, using an
antibody raised against an osteopontin-related 20 kD protein
secreted by the MDCK cell line, performed immunocytochemistry
on rat kidneys perfusion fixed with 4% paraformaldehyde, 0.5%
glutaraldehyde, phosphate-buffered 0.5% NaC1 [211. They found
staining in all parts of the nephron, including DTL at its origin
from PCT S3 and inner medullary collecting duct. Brown et al
performed immunohistochemistry and in situ hybridization in
human tissues using, respectively, an antibody made against
osteopontin isolated from human milk and a riboprobe made
from a mammary cDNA library using PCR [23]. They observed
immunoperoxidase staining of distal tubules and medullary col-
lecting ducts. Message was noted in "selected distal tubular
epithelium" in kidney medulla. Lopez et al performed similar
studies in mouse kidney using a variety of antibodies and an RNA
probe made from +89 to +1079 of 2ar [271. This group observed
osteopontin expression irregularly in thick ascending limbs and
distal convoluted tubules, at the apical surfaces of cells. Kohri and
coworkers recently reported immunocytochemical staining in rat
kidney using a monoclonal antibody against rat osteopontin [281.
They were unable to detect staining in any structures unless the
sections were treated with acid-urea to reveal a "cryptic epitope."
After such treatment, distal tubules were weakly positive for
osteopontin. This group also performed in situ hybridization using
a probe made from 2ar. They identified osteopontin mRNA
sporadically in ". . . distal tubular cells in the renal medulla ..,"an
imprecise histological designation. Finally, Giachelli et al, in a
study in which they show increased expression of the protein in a
model of tubulointerstitial nephritis, report similar immunocyto-
chemical findings as those of Kohri, apparently using the same
antibody [29]. In situ hybridization in control rats with a probe
made from a different cDNA showed a low intensity signal over
(distal?) tubule cells and cells of Bowman's capsule in the cortex
and over collecting duct cells and epithelial lining cells of medulla,
although in the latter case no photomicrograph is shown. It is
apparent, therefore, that controversy exists regarding which
nephron segments contain osteopontin or a related protein, which
nephron segments demonstrate message encoding osteopontin,
and even whether the osteopontin observed is synthesized within
the kidney cells or has been endocytosed from an extracellular
source.
The current study clearly shows osteopontin protein by immu-
nocytochemistry and osteopontin message by in situ hybridization
at two sites in the rat kidney: in the PSE and in the DTL. At the
former site, the immunocytochemical signal was most marked in
the calyceal fornix and tapered off both towards the papillary tip
and around the outside of the calyx; in the DTL, osteopontin
immunostaining was primarily observed in the early part of the
segment, primarily within the outer medulla. Colocalization of
both protein and message strongly supports the contention that
osteopontin is being made at these two sites. This is supported by
the fact that protein synthesis inhibition caused a rapid reduction
in the level of detectable osteopontin in these two locations.
Furthermore, the quite different localizations of osteopontin and
the lysosomal glycoprotein LGP 120, combined with the failure to
colocalize internalized FITC-dextran uptake and osteopontin
immunostaining at these sites makes it unlikely that osteopontin is
being picked up from extracellular sites. In the renal cortex,
however, the occasional observation of distal or connecting tubule
osteopontin in a pattern similar to that of LGP 120, together with
the complete absence of a signal at this location by in situ
hybridization, suggests that osteopontin could be taken up from
tubular fluid in these segments.
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The reasons for the differences between the current study and
those referred to above are not completely apparent. In some of
the studies, kidneys were fixed by immersion rather than the
perfusion fixation used in the current study. Depending upon the
rapidity of fixation, osteopontin may have been degraded or may
have diffused away from the sites of production. Unfixed frozen
kidneys, for example, do not reveal an osteopontin signal (data
not shown). Diffusion of osteopontin from DTL, in particular, and
uptake into downstream sites during tissue preparation could be
responsible for some of the reports of osteopontin immunostain-
ing in thick ascending limb and more distal segments as observed
in a number of the studies. Problems with tissue preservation may
also account for some of the differences in localization of os-
teopontin mRNA. Ischemia, for example, appears to activate
osteopontin expression and, presumably, message in a number of
nephron segments 3O].
Although the antiserum used was raised against a protein
isolated from the medium from cultured mouse cells, it is unlikely
that it is recognizing something other than rat osteopontin. First,
immunocytochemistry gave the same results with either unpuri-
fied or affinity-purified antibody. In addition, the probe used for in
situ hybridization was transcribed from a cDNA for mouse
osteopontin which codes for a protein that is 85% identical with
the rat protein.
Immunogold electron microscopy demonstrated osteopontin in
a population of vesicles in the apical portion of DTL and of the
PSE. This result, together with the finding of significant osteopon-
tin levels in rat urine by ELISA, suggest that this protein is being
secreted into tubular fluid or urine by DTL cells and PSE cells,
respectively. Given its property of inhibiting stone mineral crystal
growth [1], it may be significant that osteopontin appears to be
produced and secreted at sites at or just proximal to where urine
is likely to be most highly supersaturated in stone mineral
constituents.
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